To Be Discontinued Injection Anesthesia
Ketamine Hydrochloride Injec · 308 days since initial FDA posting
Brand: KETAMINE HYDROCHLORIDE
FDA lists Ketamine Hydrochloride Injec as To Be Discontinued (Pfizer Inc.).
No availability text on this FDA row.
Ketamine Hydrochloride Injection: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Ketamine Hydrochloride Injection
- Manufacturer
- Pfizer Inc.
- Dosage Form
- Injection
- Presentation
- Ketamine Hydrochloride, Injection, 500 mg/5mL (100 mg/mL); Multiple Dose Glass Fliptop Vial Novaplus (NDC 0409-0040-10)
- Package NDC
- 0409-0040-10
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Nov 7, 2025
- Last Updated
- Nov 7, 2025
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.